筛选此附件
本附件的作用方式
Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.
- 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
- Prohibition covers intentional addition; there is no permitted concentration.
- Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
- Absence from Annex II is not permission — most substances appear in no annex at all.
Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.
The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.
Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.
The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.
核对依据
附件 II 记录
1739 共| 条目 | 物质 | CAS | 最大浓度 |
|---|---|---|---|
| 1728 | Gold (nano) [INCI], Colloidal Gold (nano) [INCI] [1] Gold Thioethylamino Hyaluronic Acid (nano) [INCI] [2] Acetyl heptapeptide-9 Colloidal gold (nano) [INCI] [3]CAS 7440-57-5[1] / 1360157-34-1[2] / -[3] | 7440-57-5[1] / 1360157-34-1[2] / -[3] | — |
| 1729 | Platinum (nano) [INCI], Colloidal Platinum (nano) [INCI] [1] Acetyl tetrapeptide-17 Colloidal Platinum (nano) [INCI] [2]CAS 7440-06-4[1] / -[2] | 7440-06-4[1] / -[2] | — |
| 1730 | 3-(4'-methylbenzylidene)-camphor[INCI: 4-Methylbenzylidene Camphor]CAS 36861-47-9 / 38102-62-4 | 36861-47-9 / 38102-62-4 | — |
| 1731 | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxideINCI: Trimethylbenzoyl Diphenylphosphine OxideCAS 75980-60-8 | 75980-60-8 | — |
| 1732 | 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenoltetrabromobisphenol-ACAS 79-94-7 | 79-94-7 | — |
| 1733 | transfluthrin (ISO)2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylateCAS 118712-89-3 | 118712-89-3 | — |
| 1734 | clothianidin (ISO)(E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidineCAS 210880-92-5 | 210880-92-5 | — |
| 1735 | benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolateCAS 577705-90-9 | 577705-90-9 | — |
| 1736 | benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)CAS 75768-65-9 | 75768-65-9 | — |
| 1737 | reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1) | — | — |
| 1738 | reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (1:1) | — | — |
| 1739 | dimethyl propylphosphonateCAS 18755-43-6 | 18755-43-6 | — |
| 1740 | dibutyltin maleateCAS 78-04-6 | 78-04-6 | — |
| 1741 | dibutyltin oxideCAS 818-08-6 | 818-08-6 | — |
| 1742 | reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3-epoxypropoxy)methyl)-2-hydroxymethyl butane | — | — |
| 1743 | 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenolbisphenol AFCAS 1478-61-1 | 1478-61-1 | — |
| 1744 | benfluralin (ISO)N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidineCAS 1861-40-1 | 1861-40-1 | — |
| 1745 | N,N-dimethyl-p-toluidineCAS 99-97-8 | 99-97-8 | — |
| 1746 | 1,4-Benzenediamine, N,N’-mixed Ph and tolyl derivs.CAS 68953-84-4 | 68953-84-4 | — |
| 1747 | 4-nitrosomorpholineCAS 59-89-2 | 59-89-2 | — |
| 1748 | difenoconazole (ISO)1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS; 2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl etherCAS 119446-68-3 | 119446-68-3 | — |
| 1749 | 4-methylimidazoleCAS 822-36-6 | 822-36-6 | — |
| 1750 | 3,3'-dimethylbiphenyl-4,4'-diyl diisocyanateCAS 91-97-4 | 91-97-4 | — |
| 1751 | foramsulfuron (ISO)2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)ureaCAS 173159-57-4 | 173159-57-4 | — |
| 1752 | Multi-walled Carbon Tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 μm and a length ≥ 5 μm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T | — | — |
| 1753 | reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol | — | — |
| 1754 | Acetone oximeCAS 127-06-0 | 127-06-0 | — |
| 1755 | 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-oneCAS 119344-86-4 | 119344-86-4 | — |
| 1756 | 2,3-epoxypropyl neodecanoateCAS 26761-45-5 | 26761-45-5 | — |
| 1757 | Benthiavalicarb-isopropyl (ISO)isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamateCAS 177406-68-7 | 177406-68-7 | — |
| 1758 | 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylateCAS 2386-87-0 | 2386-87-0 | — |
| 1759 | Sodium 3-(allyloxy)-2-hydroxypropanesulphonateCAS 52556-42-0 | 52556-42-0 | — |
| 1760 | 1,4-dichloro-2-nitrobenzeneCAS 89-61-2 | 89-61-2 | — |
| 1761 | Fenpropidin (ISO)(R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidineCAS 67306-00-7 | 67306-00-7 | — |
| 1762 | N,N’-methylenediacrylamideCAS 110-26-9 | 110-26-9 | — |
| 1763 | tert-butyl 2-ethylperoxyhexanoateCAS 3006-82-4 | 3006-82-4 | — |
| 1764 | Trimethyl borateCAS 121-43-7 | 121-43-7 | — |
| 1765 | S-metolachlor (ISO)2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (R a S a)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide]CAS 87392-12-9 | 87392-12-9 | — |
| 1766 | Pyraclostrobin (ISO)methyl N-(2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl) N-methoxy carbamateCAS 175013-18-0 | 175013-18-0 | — |
如何使用此分组视图
附件 II 包含化妆品禁用物质。当您想按名称、标识符和关联条目页面快速浏览 1739 条禁用物质记录时,请使用此分组视图。
当您需要完整的法律措辞、浓度逻辑、警示语或相关标识符的交叉链接时,请打开单条记录。